GLP1R and obesity due to melanocortin 4 receptor deficiency: However, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is promoting the belief that drug-based management of obesity may be possible for long-term treatment with suitable tolerability and safety.